Graft versus Host Disease
Stay up to date on practice-changing data in community practice.
Improving Quality of Life in LR-MDS Through Anemia Treatment
During a live event, Chris Benton, MD, discussed the focus on anemia management, reducing transfusions, and improving quality of life in MDS.
Read More
SGX301 Shows Rapid and Durable Responses in Early-Stage CTCL
SGX301 has shown rapid and sustained benefit in early cutaneous T-cell lymphoma in an investigator-initiated study, with good safety.
AFM13/NK Cell Combination Shows Encouraging Responses in R/R Lymphoma
AFM13-NK combo shows high response rates in relapsed/refractory lymphoma trial, per survival data reported at 20 months.
FDA OKs Phase 3 Study of Linperlisib in Peripheral T-Cell Lymphoma
Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma.
Optimizing Tagraxofusp in BPDCN with Early CPS Detection Strategies
Marlise R. Luskin, MD, MSCE, discusses the vigilant monitoring required for capillary leak syndrome with tagraxofusp in BPDCN.
AlloHeme Enhances Early Relapse Detection in AML and MDS Post-Transplant
Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients with AML and MDS.
